Navigation Links
Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials
Date:8/19/2009

ARGONNE, Ill. (Aug. 19, 2009) Scientists from the U.S. Department of Energy's (DOE) Argonne National Laboratory and the University of Chicago's Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to soft biological material.

Thousands of people die from malignant brain tumors every year, and the tumors are resistant to conventional therapies. This nano-bio technology may eventually provide an alternative form of therapy that targets only cancer cells and does not affect normal living tissue.

"It is a real example of how nano and biological interfacing can be used for biomedical application," said scientist Elena Rozhkova with Argonne's Center for Nanoscale Materials. "We chose brain cancer because of its difficulty in treatment and its unique receptors."

This new therapy relies on a two-pronged approach. Titanium dioxide is a versatile photoreactive nanomaterial that can be bonded with biomolecules. When linked to an antibody nanoparticles recognize and bind specifically to cancer cells. Focused visible light is shined onto the affected region, and the localized titanium dioxide reacts to the light by creating free oxygen radicals that interact with the mitochondria in the cancer cells. Mitochondria act as cellular energy plants, and when free radicals interfere with their biochemical pathways, mitochondria receive a signal to start cell death.

"The significance of this work lies in our ability to effectively target nanoparticles to specific cell surface receptors expressed on brain cancer cells," said Dr. Maciej S. Lesniak, Director of Neurosurgical Oncology at University of Chicago Brain Tumor Center. "In so doing, we have overcome a major limitation involving the application of nanoparticles in medicine, namely the potential of these agents to distribute throughout the body. We are now in a position to develop this exciting technology in preclinical
'/>"/>

Contact: Brock Cooper
bcooper@anl.gov
630-252-5565
DOE/Argonne National Laboratory
Source:Eurekalert

Page: 1 2

Related medicine news :

1. University of Iowa professor identifies new eating disorder
2. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. Tulane University to receive $14M for international HIV/AIDS program
5. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
6. Boston University School of Medicine researcher recipient of Memory Ride Grant
7. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
8. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
9. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
10. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
11. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... with nasal septum cells. Researchers at the University and ... from the nasal septum are able to adapt to ... repair articular cartilage defects. The nasal cartilage cells, ability ... associated with the expression of so-called HOX genes. The ... the research results together with the report of the ...
(Date:8/28/2014)... working out how to safely increase the radiotherapy dose ... local control and survival. , Standard treatment for locally ... radiotherapy and chemotherapy. Traditionally this is planned in a ... be enough to stop tumour growth. , The potential ... varies between patients and depends on the size and ...
(Date:8/28/2014)... 28, 2014 Parker Waichman LLP, a ... years fighting to ensure that the heroes of 9/11 ... coverage to WTC victims who developed 9/11-related cancer was ... Accountability Office (GAO). According to a statement issued by ... report is entitled “World Trade Center Health Program: Approach ...
(Date:8/28/2014)... By Steven Reinberg ... -- Treating pre-cancerous skin spots with a type of light ... freezing the lesions with liquid nitrogen, a new study suggests. ... on the scalp and face of people with fair complexions ... review of prior research found that people who underwent the ...
(Date:8/28/2014)... Alexandria, VA (PRWEB) August 28, 2014 ... Foundation) will interview Stephen Isaacs, the chairperson, president and ... the Foundation’s Meet the Mesothelioma Experts live ... Foundation’s executive director and mesothelioma expert nurse practitioner, ... the interview will be Aduro BioTech’s experimental therapy for ...
Breaking Medicine News(10 mins):Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Research demonstrates potential method to better control lung cancer using radiotherapy 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 2Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 3Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 3
... 22 Although Attention Deficit ... as only affecting children, for nearly 9 million adults ... reality. According to the National Institutes of Mental Health, ... to a job, remembering or keeping appointments and being ...
... Earn Decision Resources, Clinical Gold Standard Status for ... Report from Decision ResourcesWALTHAM, Mass., April 22 ... and advisory firms for pharmaceutical and healthcare issues, ... on overall survival as the attribute that most ...
... -- Drug side effects are a major problem,for the ... can warrant,drug withdrawal. Unfortunately, these problems often emerge only ... millions of patients. , Identifying ... the,clinic is a major focus of ReproCELL. Current cardiotoxicity ...
... New Plan Designs Help Employers and Their Employees Manage ... Life Insurance Company of America (Guardian), one of the ... employee and voluntary benefits for small and mid-sized companies, ... lineup that will broaden access to more affordable dental ...
... April 22 Celator Pharmaceuticals today ... CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in consolidation treatment for ... in combination with biological agents for the treatment ... Annual Meeting of the American Association for Cancer ...
... 22 /PRNewswire-FirstCall/ - Hard To Treat Diseases (HTDS) ... Sanja Pekovic provided updates from a recent medical ... Gesellschaft - Nederlandse Anatomen Vereniging, Antwerpen, 27-30 March ... of recent positive testing being conducted related to ...
Cached Medicine News:Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 2Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 3Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 4Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 5Health News:Surveyed Experts Indicate That the Combination of Sutent and Taxol Has Advantages Over the Combination of Avastin and Taxol in the Treatment of Metastatic Triple-Negative Breast Cancer 2Health News:Surveyed Experts Indicate That the Combination of Sutent and Taxol Has Advantages Over the Combination of Avastin and Taxol in the Treatment of Metastatic Triple-Negative Breast Cancer 3Health News:New Stem Cell Technology to Improve Drug Safety 2Health News:Guardian Adds New Cost-Conscious Options to Group Dental Lineup 2Health News:Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research 2Health News:Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research 3Health News:Hard To Treat Diseases (HTDS) Slavica BioChem Update on Research Activities 2Health News:Hard To Treat Diseases (HTDS) Slavica BioChem Update on Research Activities 3
(Date:8/28/2014)... LONDON , Aug. 28, 2014  A candidate Ebola ... Gambia and Mali ... trials of potential vaccines aimed at preventing the disease that has ... West Africa . Human trials of this ... (NIH) and GlaxoSmithKline, are to be accelerated with funding from an ...
(Date:8/28/2014)... , Aug. 28, 2014 Nonin Medical, ... leader in noninvasive medical monitoring, today announced that the ... Model 3231 OEM/eHealth finger pulse oximeter for use in ... pulse oximeter plugs into a telemedicine hub or kiosk ... pulse rate in pediatric to adult patients. The Model ...
(Date:8/28/2014)... , Aug. 28, 2014   Edison ... today announced a worldwide search for product ideas ... senior population.  Promising ideas uncovered through the 6-month ... leading medical device manufacturers and healthcare retailers with ... the lives of individuals age 65 and older. ...
Breaking Medicine Technology:Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3
... Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced ... ® (topiramate) 100mg Tablets.  These two lots ... in the U.S. and Puerto Rico.  While the ... , the company believes there are fewer than ...
... (Nasdaq: CDXS ) today announced the company will ... 2011 at 4:30 p.m. Eastern Time to discuss its first ... 2011.  The call and webcast will follow the release of ... of the call will be available approximately one hour after ...
Cached Medicine Technology:Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 2Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 3Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 4Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: